'Abbreviations used in this paper: LD, lymphocyte defined; MLC, mixed lymphocyte culture; RA, rheumatoid arthritis.
of rheumatoid factors, diffuse hyperplasia of lymphoid tissue, and overt changes in the synovial membrane of involved joints that characterize an ongoing immune response (1) . Both thymus-derived and bone marrowderived lymphocytes have been shown to be present in the lesions (2) (3) (4) and their secretion products have been found in synovial fluids and in cultures of explants of synovial tissues. Thus, rheumatoid synovium produces immunoglobulin in large amounts (5) and the joint fluids have been shown to contain lymphokine-like materials (6) . In other studies it was found that peripheral blood lymphocytes from patients with RA were unreactive in mixed lymphocyte cultures (MLC) against cells from other RA patients (7) however the mechanism of unreactivity was not elucidated. One hypothesis was that it reflects an abnormality in the function of lymphocytes or of phagocytic cells and therefore perhaps manifestation of a defect of cellular immunity associated with pathogenesis of the disease (8) . Reactions in MLCs are known to result from recognition of the lymphocytedefined (LD) histocompatibility determinants which are products of loci close to, but separate from the A (LA), B (Four), and C (AJ) loci of the HLA region, (9) (10) (11) , Typing for these determinants is now made possible through the use of LD homozygous MLC-typing cells (12) (13) (14) (15) . In the present work methods commonly used in histocompatibility studies were applied to the investigation of MLC reactions of lymphocytes in patients with RA. In preliminary experiments (16) , low MLC reactions occurred in a small group of random RA patients and it was suggested that they may represent LD-typing responses. The results obtained subsequently in a larger group indicate that the low responses followed definable patterns and did not appear to be due to extrinsic factors or cellular defects, but rather depended on the sharing of genetically determined LD determinants among RA patients.
METHODS
Study subjects. RA 14 were black, 9 were Latin American, and 1 was of American Indian background. At the time of the study most of them were taking aspirin, some were also treated with indomethacin or small doses (less than 10 mg/day) of prednisolone, and about half of the patients were receiving injections of gold salts. A group of 50 nonrheumatoid subjects was also studied. These controls consisted of 24 patients with miscellaneous conditions other than RA and 26 normal subjects including laboratory personnel and normal relatives of kidney transplant recipients. Also studied were the members of a family of a patient (A. C.) with RA consisting of 12 nonaffected relatives of three generations. In addition, MLC results in 35 families of kidney transplant recipients were analyzed to test the effect of expressing results as relative responses.
MLCs. The MLC tests were performed using a microtiter plate technique (17) with some modifications. Blood was drawn into an equal volume of heparinized medium RPMI 1640 and lymphocytes were separated by flotation on FicollHypaque (Lymphoprep, Nyegaard, Oslo) as described by Boyum (18) . The cells were washed once in RPMI 1640, buffered with bicarbonate (24 mM) and Hepes (20 mM), and then resuspended in the same medium containing 10% pooled normal human serum to a concentration of 5 X 10' mononuclear cells/ml. In earlier experiments, stimulating cells were treated with mitomycin C. In more recent experiments they were X-irradiated with 3,000 rads using a 'Cs source which delivers 110 rads/min. Both procedures were found to give equivalent results but the latter was more convenient when performing large cultures. Cultures were performed in round-bottomed Linbro microtiter plates (Linbro Chemical Co., New Haven, Conn. IS-MRC-96-TC). Each reaction well contained 5 X 10' responding and 5 X 10' stimulating cells in a total volume of 0.2 ml. Triplicate plates were incubated at 37°C in a moist atmosphere containing 5%o C02, 95% air. On the evening of the 6th day, tritiated thymidine 2 guCi sp act 5.0 Ci/mmol was added to each well and 16 h later the cells were harvested using a multiple sample harvesting device (17) of our own design. Glass fiber filters (Reeve-Angel 943AH) containing the harvested lymphocytes were dried and then transferred to scintillation vials for counting with 5 ml of liquifluor (New England Nuclear, Boston, Mass.) in a liquid scintillation counter.
Results were expressed in the form of relative responses (13) . This was found to be most suitable for evaluation of results because it largely eliminates the effect of day-today variation in the level of tritiated thymidine incorporation. The basis of the calculations was the median of the triplicate counts for each culture combination. Several unrelated stimulating cells were included in each experiment to serve as reference for normalization. The median of these normal 2-haplotype responses was used in the formula for calculation of relative responses as follows:
Relative Response (%) cpm stimulated culture-medium control cpm normal 2-haplo response-medium control The relative response therefore was expressed as a percentage of the normal 2-haplotype response of each cell which was obtained from the control cultures. The stimulation index was also calculated using the formula: Stimulation Index=ABm/AAm in which ABm represents counts per minute in the stimulated culture and AAm, counts per minute obtained in the autologous control. (19) . The HLA typing reagents used were obtained from the NIH Serum Bank, from other investigators, and from our own pregnancy serum screening program (20 (Fig. 1) . When on the basis of HL-A genotyping there was a 1-haplotype difference between the responding and the stimulating cell, the reactions tended to cluster around 50%. In the group of cultures where the stimulator had no LD determinant not present in the responder, stimulation was low or absent, ranging from 0 to 20%. There was good separation between the 0-haplotype and the other two groups as shown by their 95% confidence limits (Fig. 1) . When the 0-haplotype difference resulted from an LD heterozygous responder reacting to an LD homozygous stimulator higher values were often observed as has been found also by others (13 In the cultures of RA patients against non-RA control subjects no low responses occurred. In the control group of cultures between non-RA subjects there were three low responses. The stimulator involved, J. L., a normal laboratory technician, was homozygous for the HLA antigens Al, B8, and LD homozygous by family study (21 Table I , low reactions were present in 10, the with a dividing line that accurately separated the two populations.
Low MLC reactions in random RA patients and controls. Having thus defined the interpretation of MLC results, random one-way cultures were performed in checkerboard fashion between 43 patients with RA and 45 non-RA subjects. The cultures were divided into four groups two of which consisted of RA responders stimulated either by other RA patients or by non-RA subjects (A and B in Fig. 2 ), and the other two were non-RA control responders cultured with either RA or control stimulators (C and D in Fig. 2 ). The results were evaluated as relative responses and those below 38% were considered low. In the group of RA responders vs. RA stimulators, 31 low MLC reactions were identified ( Fig. 2A) . Of interest is the fact that these low MLC reactions occurred repeatedly with the same RA stimulator cells. Only 8 out of the 43 RA patients studied functioned as low stimulators and the majority of the low reactions occurred with only two of these. Repeated tests with lymphocytes obtained from the same subjects on different days were found to be highly reproducible. The other 35 RA stimulators always elicited normal responses.
In the group of control subjects cultured against RA stimulators six low reactions occurred. All of them were with the two RA stimulators who elicited low responses most frequently in the RA vs. RA group (Fig. 2 ). (Table II) . The median value of the 2-haplotype responses was used as an indication of the overall level of tritiated thymidine incorporation. There was no difference in this parameter between RA patients with and without low MLC responses while in the non-RA group, the six subjects with low MLC reactions had a somewhat lower 2-haplotype response (Table II) . Aspirin was used by 23 out of 31 RA patients with low responses and by 9 of 12 that did not show a low response. The average intake of the drug was not significantly different between the two groups. There were more RA patients taking prednisolone in the low responder group but the two patients taking 10 mg/day did not have any low responses. In both groups of RA patients, many were receiving gold salts but none of the controls were treated with this drug. Thus, it appears that there was no correlation between low responses and drug intake by these patients. It seems unlikely that the low responses observed could have been caused by these agents. In the case of patient A. C. (A. C. was the first RA stimulator in Fig. 1 ) it was shown that about half of the random adult RA patients tested as responders produced low responses. Therefore, the possibility that A. C. might be LD homozygous seemed reasonable and was examined by performing HLA and MLC tests among the members of her family. 12 individuals belonging to three generations were investigated. The results are summarized in Fig. 3 . The haplotypes HLA-A3, B7 and HLA-A9, BW15 were present in A. C. and in her sister 1,3. The other sister (I,4) shared the haplotype HLA-A3. B7 and her other haplotype was HLA-A2, BW15. The HLA-A3, B7 haplotype was also present in subjects II,1; II,4, and II,5 of the second generation and in subject III,2 of the third. The results of MLC studies are shown in Table IV . A. C. and 1,3 who were HLA identical were also mutually nonstimulatory. Several other family members produced very low response to A. C. (I,4; II,1; 11,4; II,5 and III,2). In each case these were the persons that had received the HLA-A3, B7 haplotype. In the case II,1 and 111,2, the haplotype was derived directly from A. C. In the other family members it was inherited through her sister I,4. The reciprocal reactions of A. C. responding against the same family members in every case produced strong stimulation, indicating that the other LD haplotype in these persons was not similar to that of A. C. In Fig. 3 I,2) and of producing a blastogenic factor. Such a factor has been shown to be produced by mitomycintreated lymphocytes (22) .
Frequency of LD-typing reactions to A. C. and A. W. Two rheumatoid patients when used as stimulators were responsible for the majority of the low MLC reactions observed. One of them was A. C., who was shown by family study to be LD homozygous. The minants that were defined with these two typing cells DISCUSSION (Table V) . The 50 control subjects who were tested An important finding in the present experiments was simultaneously with the RA patients showed a combined that the majority of MLC reactions in patients with RA frequency of only 12%.
were normal. The results were in that regard not identical to those of previous workers who reported absence of stimulation or very low responses in mixed cultures TABLE V between over half of the RA patients tested (7, 8 (24) and reduced responses have been reported in patients after oral intake of aspirin (25) Although it seems unlikely that enough serum was retained after washing the cells to influence the culture results, two other circumstances that might have influenced the outcome were considered. The first was that lymphocytes of certain patients could have been coated by inhibitory factors in vivo. Marked reduction of MLC responsiveness in patients with systemic lupus erythematosus apparently caused by lymphocyte autoantibodies was shown by Wernet et al. (26) to be reversible after short-term culture in medium with normal serum. In the present experiments it was found that culture for 24 h and washing before admixture with allogeneic cells had no effect on the low responses observed. Since no significant increase in either responsiveness or stimulating capacity was observed after incubation times which should have allowed at least some removal of surface components, the possibility of blocking of the lymphocytes by antibodies bound in vivo seems unlikely.
The second possibility considered was the production of inhibitory factors by B (28) . A strong association has also been reported between the HLA-D allele DW2 (previously called LD7a) and the development of multiple sclerosis (29) . In fact a patient with multiple sclerosis homozygous for DW2 was used for MLC typing. In multiple sclerosis also an association with HLA-A3 and HLA-B7, has been recognized in several laboratories (30) (31) (32) . No such association with HLA-A or HLA-B locus alleles appears to exist in RA (33) (34) (35) . Nevertheless sharing of alleles of the HLA-D locus could occur independently of the other HLA genes and would provide a satisfactory explanation of the present experimental findings.
The results of the family study showed that patient A. C. who was the stimulator most frequently involved in low responses, was indeed HLA-D homozygous. Because this LD determinant was found in a patient with RA it has temporarily been called "R". 6 of the 11 other persons of her family gave very low MLC responses to her cells. All of them appeared to share the Dsame--HLA-A3, B7 haplotype. A. C. and I,3 were unresponsive in both directions suggesting that I,3 was also homozygous, which is to be expected since she was by serology HLA identical. The other five family members with low reactions to A. C. appear to be heterozygous as evidenced by the fact that they stimulated A. C.
It is interesting that individual I,3 produced higher reactions than A. C. when used as stimulator for the R heterozygous family members. The reason for this is not known. Since L,3 did not stimulate A. C., the higher values obtained when heterozygous responders were used are likely due to production of blastogenic factor (22) family study of one of these indicated that the HLA-D determinant "R" was inherited from the mother in association with one of her HLA haplotypes (16) . Thus it appears that "R" is frequently found in patients with RA but can be found also in normal individuals and in either situation is inherited in linkage with HLA.
In the course of the 6th International Histocompatibility Workshop it has been possible to compare lymphocytes from patient A. C. with other homozygous typing cells from 14 LD laboratories. Results of these studies, which will be reported in detail elsewhere, have shown that several other homozygous cells possess determinants similar to those of A. C. (36) . These cells showed strong associations in the joint analysis of the workshop LD data and characterize an allele which has received the WHO designation HLA-DW4 (28) .
Further studies of families of two other RA patients causing low MLC stimulation have also shown them to be HLA-D homozygous for determinants which although similar are not identical to those of A. C. (36) . Thus it seems likely that all or most of the low MLC reactions observed in RA patients can be explained on the basis of sharing of inherited MLC determinants. In a preliminary assessment, the frequency of these determinants in non-RA subjects was 12%, and in RA patients it was 68%. More detailed population studies using several LD homozygous typing cells will be reported in a subsequent publication. ' There has been considerable debate about the role of genetic factors in RA and the results of different studies have been far from uniform (37) . A survey of Blackfeet and Pima Indians gave no evidence of striking genetic factors, but did show a higher prevalence of RA in siblings and parents of affected persons than in agematched controls (38) . The results suggested environmental factors played the major role in the appearance of the disease. In other studies a genetic influence was suggested in adults (39) , and in children with RA (40) . The results of the present work open a new approach to inquiry into the genetics of RA. Because of the known proximity of the locus controlling strong MLC stimulation to those regulating certain specific immune responses in mice (41) and in rhesus monkeys (42) it is attractive to speculate that an Ir gene may be involved. The rapidly developing knowledge of the HLA chromosomal region which includes also loci for certain complement components (43) , cell surface receptors (44) , and disease associations (45) would indicate that many other possibilities must be considered. Since many of these possibilities are open to experimental testing with tools already available, further exploration should lead to an understanding of the mechanisms involved in 'Stastny, P. Manuscript in preparation. predisposition and possibly also provide clues regarding other factors involved in the development of RA.
